Karla Beatriz Cardias Cereja Pantoja

Ms. Karla Beatriz Cardias Cereja Pantoja

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Leukemia Research
Verified
Journal Article
Open access
DCDarlen Carvalho
Darlen Carvalho
AWAlayde V. Wanderley
Alayde V. Wanderley
MAMarcos A.T. Amador
Marcos A.T. Amador
MARIANNE RODRIGUES FERNANDESMARIANNE RODRIGUES FERNANDES
MARIANNE RODRIGUES FERNANDES
GCGiovanna Cavalcante
Giovanna Cavalcante
NSNey Santos
Ney Santos
Acute lymphoblastic leukemia (ALL) is a malignant tumor common in children. Studies of genetic susceptibility to cancer using biallelic insertion/deletion (INDEL) type polymorphisms associated with cancer development pathways may help to clarify etymology of ALL. In this study, we investigate the role of eight functional INDEL polymorphisms and influence of genetic ancestry to B-cell ALL susceptibility in children of Brazilian Amazon population, which has a high degree of inter-ethnic admixture. Ancestry analysis was estimated using a panel of 48 autosomal ancestry informative markers. 130 B-cell ALL patients and 125 healthy controls were included in this study. The odds ratios and 95% confidence intervals were adjusted for confounders. The results indicated an association between the investigated INDEL polymorphisms in CASP8 (rs3834129), CYP19A1 (rs11575899) e XRCC1 (rs3213239) genes in the development of B-cell ALL. The carriers of Insertion/Insertion (Ins/Ins) genotype of the polymorphism in CASP8 gene presented reduced chances of developing B-cell ALL (P=0.001; OR=0.353; 95% CI=0.192-0.651). The Deletion/Deletion (Del/Del) genotype of the polymorphism in CYP19A1 gene was associated to a lower chance of developing B-cell ALL (P=3.35×10-6; OR=0.121; 95% CI=0.050-0.295), while Del/Del genotype of the polymorphism in XRCC1 gene was associated to a higher chance of developing B-cell ALL (P=2.01×10-4; OR=6.559; 95% CI=2.433-17.681). We also found that Amerindian ancestry correlates with the risk of B-cell ALL. For each increase of 10% in the Amerindian ancestry results in 1.4-fold chances of developing B-cell ALL (OR=1.406; 95% IC=1.123-1.761), while each increase of 10% in the European ancestry presents a protection effect in the development of B-cell ALL (OR=0.666; 95% IC=0.536-0.827). The results suggest that genetic factors influence leukemogenesis and might be explored in the stratification of B-cell ALL risk in admixed populations.

10 February 2022 in Genes
Verified
Journal Article
Open access
PDF file
KPKarla Beatriz Cardias Cereja Pantoja
Karla Beatriz Cardias Cereja Pantoja
TATereza Cristina de Brito Azevedo
Tereza Cristina de Brito Azevedo
DCDarlen Carvalho
Darlen Carvalho
NMNatasha Monte
Natasha Monte
ACAmanda de Nazaré Cohen-Paes
Amanda de Nazaré Cohen-Paes
NSNey Santos
Ney Santos
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm derived from the balanced reciprocal translocation of chromosomes 9 and 22 t (9q34 and 22q11), which leads to the formation of the Philadelphia chromosome and fusion of the BCR-ABL genes. The first-line treatment for CML is imatinib, a tyrosine kinase inhibitor that acts on the BCR-ABL protein. However, even though it is a target-specific drug, about 25% of patients do not respond to this treatment. The resistance mechanisms involved in this process have been investigated and studies have shown that germinal alterations can influence this mechanism. The aim of this work was to investigate 32 polymorphisms in 24 genes of carcinogenic pathway to verify the influence of these genetic variants on the response to treatment with imatinib. Our results demonstrated that individuals with the recessive GG genotype for the rs2372536 variant in the ATIC gene are approximately three times more likely to experience treatment failure with imatinib (p = 0.045, HR = 2.726, 95% CI = 0.9986–7.441), as well as individuals with the TT genotype for the rs10821936 variant in the ARID5B gene, who also have a higher risk for treatment failure with imatinib over time (p = 0.02, HR = 0.4053, IC 95% = 0.1802–0.911). In conclusion, we show that variants in the ATIC and ARIDB5 gene, never screened in previous studies, could potentially influence the therapeutic response to imatinib in patients treated for CML.

24 December 2022 in Genes
Verified
Journal Article
Open access
PDF file
AMAntonio Conde Modesto
Antonio Conde Modesto
MMMilene R. de Moraes
Milene R. de Moraes
CVCristina M. D. Valente
Cristina M. D. Valente
MCMarta S. C. R. Costa
Marta S. C. R. Costa
DLDiana Feio da Veiga Borges Leal
Diana Feio da Veiga Borges Leal
SSSidney Santos
Sidney Santos
Gastric cancer (GC) is a multifactorial, complex, and aggressive disease with a prevalence of one million new cases and high global mortality. Factors such as genetic, epigenetic, and environmental changes contribute to the onset and progression of the disease. Identification of INDELs in miRNA and its target sites in current studies showed an important role in the development of cancer. In GC, miRNAs act as oncogenes or tumor suppressors, favoring important cancer pathways, such as cell proliferation and migration. This work aims to investigate INDELs in the coding region of miRNAs (hsa-miR-302c, hsa-miR-548AJ-2, hsa-miR-4274, hsa-miR-630, hsa-miR-516B-2, hsa-miR-4463, hsa-miR-3945, hsa-miR-548H_4, hsa-miR-920, has-mir-3171, and hsa-miR-3652) that may be associated with susceptibility and clinical variants of gastric cancer. For this study, 301 patients with GC and 145 individuals from the control group were selected from an admixed population in the Brazilian Amazon. The results showed the hsa-miR-4463, hsa-miR-3945, hsa-miR-548H_4, hsa-miR-920 and hsa-miR-3652 variants were associated with gastric cancer susceptibility. The hsa-miR-4463 was significantly associated with clinical features of GC such as diffuse gastric tumor histological type, “non-cardia” localization region, and early onset. Our findings indicated that INDELs could be potentially functional genetic variants for gastric cancer risk.

15 October 2022 in Genes
Verified
Journal Article
Open access
PDF file
ACAmanda de Nazaré Cohen-Paes
Amanda de Nazaré Cohen-Paes
AAAngélica Leite de Alcântara
Angélica Leite de Alcântara
Fabiano MoreiraFabiano Moreira
Fabiano Moreira
MARIANNE RODRIGUES FERNANDESMARIANNE RODRIGUES FERNANDES
MARIANNE RODRIGUES FERNANDES
KPKarla Beatriz Cardias Cereja Pantoja
Karla Beatriz Cardias Cereja Pantoja
NSNey Pereira Carneiro dos Santos
Ney Pereira Carneiro dos Santos
Native American populations from the Brazilian Amazon have a low genetic diversity and a different genetic profile when compared to people from other continents. Despite this, few studies have been conducted in this group, and there is no description of their genetic data in the various currently existent international databases. The characterization of the genomic profile of a population not only has an impact in studies of population genetics, but also helps to advance diagnostic and therapeutic response studies, leading to the optimization of clinical applicability. Genetic variations in DNA repair genes have been associated with the modulation of susceptibility to various pathologies, as well as in their prognosis and therapy. This is the first study to investigate DNA repair genes in Amerindians from the Brazilian Amazon region. We investigated 13 important DNA repair genes in the exome of 63 Native Americans, comparing our results with those found in 5 continental populations, whose data are available in the Genome Aggregation Database. Our results showed that 57 variants already described in literature were differentially distributed in the Amerindian populations in relation to the continental populations, 7 of which have significant clinical relevance. In addition, 9 new variants were described, suggesting that they are unique to these populations. Our study reinforces the understanding that the Amazonian Native American population presents a unique genetic profile, and our findings may collaborate with the creation of public policies that optimize the quality of life of these groups as well as the Brazilian population, which presents a high degree of interethnic mixing with Amerindian groups.

31 January 2023 in Genes
Verified
Journal Article
Open access
PDF file
RBRui Sergio Monteiro de Barros
Rui Sergio Monteiro de Barros
CACarla de Castro Sant' Anna
Carla de Castro Sant' Anna
DADiego Di Felipe Ávila Alcantara
Diego Di Felipe Ávila Alcantara
KPKarla Beatriz Cardias Cereja Pantoja
Karla Beatriz Cardias Cereja Pantoja
MARIANNE RODRIGUES FERNANDESMARIANNE RODRIGUES FERNANDES
MARIANNE RODRIGUES FERNANDES
Rommel Mario BurbanoRommel Mario Burbano
Rommel Mario Burbano
Background: Rotator cuff disease is one of the leading causes of musculoskeletal pain and disability, and its etiology is most likely multifactorial but remains incompletely understood. Therefore, the objective of this research was to investigate the relationship of the single-nucleotide rs820218 polymorphism of the SAP30-binding protein (SAP30BP) gene with rotator cuff tears in the Amazonian population. Methods: The case group consisted of patients who were operated on due to rotator cuff tears in a hospital in the Amazon region between 2010 and 2021, and the control group was composed of individuals who were selected after negative physical examinations for rotator cuff tears. Genomic DNA was obtained from saliva samples. For the genotyping and allelic discrimination of the selected single nucleotide polymorphism (rs820218) in the SAP30BP gene, real-time PCR was performed. Results: The frequency of the A allele in the control group was four times as high as that in the case group (AA homozygotes); an association of the genetic variant rs820218 of the SAP30BP gene with rotator cuff tears was not established (p = 0.28 and 0.20), as the A allelic frequency is ordinarily low in the general population. Conclusions: The presence of the A allele indicates protection against rotator cuff tears.

9 February 2023 in Genes
Verified
Journal Article
Open access
PDF file
RARoberta Borges Andrade
Roberta Borges Andrade
ACAmanda de Nazaré Cohen-Paes
Amanda de Nazaré Cohen-Paes
DLDiana Feio da Veiga Borges Leal
Diana Feio da Veiga Borges Leal
KPKarla Beatriz Cardias Cereja Pantoja
Karla Beatriz Cardias Cereja Pantoja
LGLaura Patrícia Albarello Gellen
Laura Patrícia Albarello Gellen
NSNey Santos
Ney Santos
Gastric cancer (GC) is the fifth most common type of cancer and the fourth leading cause of cancer death. In Brazil, GC has a high incidence and mortality rates, and it is highly variable by region. The Amazon region has significant rising rates among all Brazil regions. Only very few studies have evaluated the association between genetic variants and the risk of gastric cancer in the Brazilian Amazon population. Therefore, this study aimed to investigate associations between single nucleotide polymorphisms of miRNA processing genes and the risk for GC in this population. Potentially functional single nucleotide polymorphisms from miRNA processing genes were genotyped in 159 cases and 193 healthy controls by QuantStudio Real Time PCR. According to our findings, the genotype GG of the variant rs10739971 presents a lower risk to the development of GC in comparison to the remaining genotypes (p = 0.000016; OR = 0.055; 95% CI = 0.015–0.206). This is the first study to report the association of pri-let-7a-1 rs10739971 with GC in the Brazilian Amazon population, which is a highly mixed population with a unique genetic constitution that is different from other populations that are studied in the vast majority of scientific research.